The U.S. Food and Drug Administration (FDA) has added one lot of losartan tablets to a drug recall list of blood pressure meds. Losartan is one of several blood pressure medications found to contain trace amounts of a carcinogen known as N-nitrosodiethylamine (NDEA).
Details of the Losartan Recall
NDEA is probable human carcinogen that can cause cell damage when ingested, increasing the chance of developing cancer. The chemical is naturally present in some foods, but it’s often used to make rocket fuel and in pesticide manufacturing.
Losartan potassium/hydrochlorothiazide tablets are manufactured by Macleods Pharmaceuticals Limited.
Recall of Blood Pressure Meds Began in 2018
According to Fortune Magazine, pharmaceutical companies have recalled multiple blood pressure medications since 2018. In that time, traces of NDEA have been found in valsartan, hydrochlorothazide, irbesartan, and now losartan tablets.
FDA Continues to Stress Importance of Remaining on Meds
The FDA stresses that anyone taking the affected blood pressure medications should consult with a physician or pharmacist before stopping. Stopping blood pressure medication without a proper replacement can dangerous in the short-term.
Contact an Experienced Drug Attorney
If you or a loved one has been the victim of a dangerous pharmaceutical drug or medical device, you may be entitled to compensation. You deserve dynamic representation from a law firm with the resources necessary to take on the pharmaceutical companies. Thomas J. Henry has a track record of helping clients receive record-breaking verdicts, settlements, and judgments.